– Bloomberg
Ambrx Biopharma 13D Filing Shows Darwin Global Management, Ltd. Increased Stake In Co To 26.4%
- 13D Filing
SEC Form 4
FORM 4
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a)